All articles by Phillip Broadwith – Page 22
-
Podcast
Resveratrol
Can a compound in red wine protect against heart attack and cancer? Phillip Broadwith investigates resveratrol
-
Research
Porous materials break out of covalent cage
Packing predictions open doors for new molecular sponges
-
Business
Companies urged to publish hidden clinical trial data
Researchers could acquire data and publish themselves if firms refuse
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing
-
Business
Industry reaches registration deadline
Data on thousands more chemicals submitted under Reach regulations
-
Business
Laboratory safety goes digital
Online video resources aim to bring industry culture to academic labs
-
Business
Japanese pharma opens compound vaults
Molecule libraries to be screened for neglected diseases
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test
-
Business
Carbon capture and storage labelled ‘farcical’
Advocacy group report highlights failings in European policy over carbon emissions
-
Business
Waste CO2-derived plastic hits tonne scale
Novomer turns emissions from ammonia plant into polymers
-
Business
$500m fine over generics fraud for Ranbaxy
Company has pleaded guilty to fabricating data and producing substandard drugs
-
News
Lords Bill proposes animal research labelling for medicines
Bill aims to underline the necessity of animal experiments, says Robert Winston
-
Business
Carbon nanotubes not commercially viable for Bayer
Company terminates Baytubes project and seeks to divest its know-how in the area
-
Business
Clinical trial data release blocked by companies
Abbvie and Intermune sue the European Medicines Agency to stop it making data public